Medtronic's pain and ICD devices:
This article was originally published in Clinica
Medtronic can now sell both its next-generation neurostimulation implant for chronic pain relief and a new implantable cardioverter- defibrillator (ICD). The SynergyPlus+ "pain pacemaker" is designed to give patients more control over the delivery of stimulation that blocks pain signals from reaching the brain while performing a variety of daily activities. It has the greatest number of programme options - up to 26 - available of any non-rechargeable neurostimulation system on the market and provides a level of therapy customisation that may result in fewer physician follow-up visits, claims the firm. The EnTrust single- and dual-chamber ICDs employ Medtronic's ATP During Charging feature, which automatically uses pacing pulses to painlessly stop fast, dangerous heartbeats, while concurrently preparing to deliver a shock if needed, with no delay.